Filtered By:
Specialty: Neurology
Condition: Multiple Sclerosis

This page shows you your search results in order of date. This is page number 8.

Order by Relevance | Date

Total 440 results found since Jan 2013.

Emotional facial palsy: an unusual and rarely explored neurological sign
AbstractThe anatomy of the cortico-bulbar tract that drives voluntary movements of mimic muscles is well described. Some cases of facial palsy with inverse automatic-voluntary dissociation (emotional facial palsy; EFP) are reported in the literature. These cases suggested a completely independent path of the fibers whose lesion results in EFP. We aimed to review the clinical reports of EFP available in the literature to characterize the anatomical aspect of the fibers whose lesion results in the isolated impairment of spontaneous smiling. Cortico-pontine fibers that control spontaneous smiling arise from the medial surface...
Source: Neurological Sciences - July 11, 2022 Category: Neurology Source Type: research

CNS Antigen-Specific Neuroinflammation Attenuates Ischemic Stroke With Involvement of Polarized Myeloid Cells
Discussion CNS autoantigen-specific autoimmunity has a protective influence on primary tissue damage after experimental stroke, indicating a very early involvement of CNS antigen-specific, myeloid cell-associated anti-inflammatory immune mechanisms that mitigate ischemic injury in the acute EAE phase.
Source: Neurology Neuroimmunology and Neuroinflammation - June 8, 2022 Category: Neurology Authors: Guse, K., Hagemann, N., Thiele, L., Remlinger, J., Salmen, A., Hoepner, R., Keller, I., Meyer, P., Grandgirard, D., Leib, S. L., Vassella, E., Locatelli, G., Hermann, D. M., Chan, A. Tags: All Immunology, Multiple sclerosis, Infarction Research Article Source Type: research

Safety and Clinical Efficacy of Mesenchymal Stem Cell Treatment in Traumatic Spinal Cord Injury, Multiple Sclerosis and Ischemic Stroke – A Systematic Review and Meta-Analysis
BackgroundMesenchymal stem cells (MSCs) is an attractive candidate in regenerative research and clinical trials have assessed their therapeutic potential in different neurological conditions with disparate etiologies. In this systematic review, we aimed to assess safety and clinical effect of MSC treatment in traumatic spinal cord injury (TSCI), multiple sclerosis (MS) and ischemic stroke (IS).MethodsA systematic search was performed 2021-12-10 in MEDLINE, EMBASE, Web of Science and Cochrane where clinical studies assessing MSC treatment in TSCI, MS or IS were included. Studies without control group were excluded for effic...
Source: Frontiers in Neurology - May 30, 2022 Category: Neurology Source Type: research

Recent Synergy of Nanodiamonds: Role in Brain-Targeted Drug Delivery for the Management of Neurological Disorders
AbstractThe aim of the present review article is to summarize the role of nanodiamonds in various neurological diseases. We have taken related literature of making this review article from ScienceDirect, springer, Research gate, PubMed, Sci-finder, etc. The current approaches for treating neurological conditions such as glioblastoma includes chemotherapy or combination anti-retro viral therapy for HIV (human immunodeficiency virus) or use of anti-Alzheimer drugs during cognitive impairment. These approaches can provide only symptomatic relief as they do not target the cause of the disease due to their inability to penetrat...
Source: Molecular Neurobiology - May 27, 2022 Category: Neurology Source Type: research

Transcranial Magnetic Stimulation in the Treatment of Neurological Diseases
Transcranial Magnetic Stimulation (TMS) has widespread use in research and clinical application. For psychiatric applications, such as depression or OCD, repetitive TMS protocols (rTMS) are an established and globally applied treatment option. While promising, rTMS is not yet as common in treating neurological diseases, except for neurorehabilitation after (motor) stroke and neuropathic pain treatment. This may soon change. New clinical studies testing the potential of rTMS in various other neurological conditions appear at a rapid pace. This can prove challenging for both practitioners and clinical researchers. Although m...
Source: Frontiers in Neurology - May 20, 2022 Category: Neurology Source Type: research

Central Neuropathic Pain Syndromes: Current and Emerging Pharmacological Strategies
AbstractCentral neuropathic pain is caused by a disease or lesion of the brain or spinal cord. It is difficult to predict which patients will develop central pain syndromes after a central nervous system injury, but depending on the etiology, lifetime prevalence may be greater than 50%. The resulting pain is often highly distressing and difficult to treat, with no specific treatment guidelines currently available. This narrative review discusses mechanisms contributing to central neuropathic pain, and focuses on pharmacological approaches for managing common central neuropathic pain conditions such as central post-stroke p...
Source: CNS Drugs - May 5, 2022 Category: Neurology Source Type: research

Neurological manifestations of COVID ‐19: A potential gate to the determinants of a poor prognosis
ConclusionCOVID-19 neurologic complications are key drivers of patient severity and mortality. Headache, convulsions, mental and psychic disorders, delirium, and insomnia are just some of the symptoms that the virus can cause. The olfactory nerve is the most commonly damaged cranial nerve, resulting in anosmia. Stroke (mostly infarction), encephalitis, meningitis, Guillain –Barre syndrome, relapse of multiple sclerosis, and transverse myelitis are all symptoms and squeals.
Source: Brain and Behavior - April 27, 2022 Category: Neurology Authors: Etedal Ahmed A. Ibrahim, Ramah Isam Farah Hassan, Khabab Abbasher Hussien Mohamed Ahmed, Elmuntasir Taha Salah, Mohammed Eltahier Abdalla Omer, Mazin S. Haroun Tags: REVIEW Source Type: research

Recent Findings in Neurology: Multiple Sclerosis and Stroke Recent Findings in Neurology: Multiple Sclerosis and Stroke
Dr Christoph Diener discusses recent studies in neurology focused on multiple sclerosis and stroke.Medscape Neurology
Source: Medscape Neurology and Neurosurgery Headlines - April 6, 2022 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news

Effect of retinoic acid on the neurovascular unit: A review
Brain Res Bull. 2022 Mar 26:S0361-9230(22)00080-6. doi: 10.1016/j.brainresbull.2022.03.011. Online ahead of print.ABSTRACTRetinoic acid is a metabolic product derived from vitamin A, acting at a nuclear level to maintain the proper transcriptional activity. Moreover, this molecule contributes to the development and maturation of the cerebral vascular system, playing a pivotal role in development and maintenance of neurovascular unit integrity. This physiological structure is comprised of glial cells, vascular cells, and neurons, ensuring the correct function of the blood-brain barrier and, at last instance, the homeostasis...
Source: Brain Research Bulletin - March 30, 2022 Category: Neurology Authors: Manuel R Pouso Elisa Cairrao Source Type: research

Evaluation of the Psychometric Properties of Jebsen Taylor Hand Function Test (JTHFT) in Italian Individuals With Multiple Sclerosis
This study aimed to evaluate the psychometric properties of the JTHFT in Italian adults with Multiple Sclerosis (MS).Materials and MethodsThe test's internal consistency was evaluated with Cronbach's alpha, whereas its concurrent validity was evaluated by comparing the JTHFT with the Health Assessment Questionnaire (HAQ) and by calculating Pearson's correlation coefficient.ResultsThe JTHFT was administered to 29 Italians with MS. The Cronbach's alpha showed that the nondominant hand has a value of 0.76 and 0.91 for the dominant hand. Pearson's correlation coefficient showed significant correlations between JTHFT and HAQ.Di...
Source: Frontiers in Neurology - March 18, 2022 Category: Neurology Source Type: research